With a very small - only $25K - SBIR involvement ,management describe the firm as deploying nanotechnology-enabled, multifunctional medical devices made from FDA-approved materials and fabricated with additive manufacturing techniques. The effort indicated is that such nano-enabled technology could drastically improve how warfighters are traeted along with, people without proper medical access and/or chronic wound patients. The firm is currently indicated as currently working on the development of "Hemosite Hemostatic Gauze" : bandage capable of regenerating tissue, eliminating infection, and drastically decreasing localized pain/inflammation. A newly developed technology is indicated as capabl eof being tailored to many different patients for severe burns and trauma, diabetic wounds, and life-saving coagulants for hemostasis. The firm's technology is allso indicated as available to be used to load other drugs to fight cancer, inhibit growth, or stimulate angiogenesis.
